Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongjun Li

Showing results (621-630 of 627) with videos related to

Pageof 63
Sort By:
You have reached the last page of results.This site can display upto 627 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2025
Phase II Pilot Trial of Tislelizumab plus Low-Dose Nab-Paclitaxel for Extensive Very High-Risk Non-Muscle-Invasive Bladder CancerYunkai Qie, Shiwang Huang, Chong Shen, et al.
European Urology Oncology|May 18, 2024
Phase 2 Study of Preoperative Tislelizumab in Combination with Low-dose Nab-Paclitaxel in Patients with Muscle-invasive Bladder CancerZhouliang Wu, Gangjian Zhao, Zhe Zhang, et al.
Nature Cancer|May 27, 2022
Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancerChaping Cheng, Jinming Wang, Penghui Xu, et al.
Nature Ecology & Evolution|September 26, 2018
Divergence and plasticity shape adaptive potential of the Pacific oysterLi Li, Ao Li, Kai Song, et al.
Emerging Microbes & Infections|November 18, 2022
Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, ChinaHongqin Xu, Hongyan Li, Hailong You, et al.
Aging and Disease|April 8, 2020
Transplantation of ACE2<sup>-</sup> Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 PneumoniaZikuan Leng, Rongjia Zhu, Wei Hou, et al.
Cancer Cell|February 25, 2024
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancerXinyuan Tong, Ayushi S Patel, Eejung Kim, et al.
Pageof 63

Showing results (621-630 of 627) with videos related to

Sort By:
Pageof 63
You have reached the last page of results.This site can display upto 627 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2025
Phase II Pilot Trial of Tislelizumab plus Low-Dose Nab-Paclitaxel for Extensive Very High-Risk Non-Muscle-Invasive Bladder CancerYunkai Qie, Shiwang Huang, Chong Shen, et al.
European Urology Oncology|May 18, 2024
Phase 2 Study of Preoperative Tislelizumab in Combination with Low-dose Nab-Paclitaxel in Patients with Muscle-invasive Bladder CancerZhouliang Wu, Gangjian Zhao, Zhe Zhang, et al.
Nature Cancer|May 27, 2022
Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancerChaping Cheng, Jinming Wang, Penghui Xu, et al.
Nature Ecology & Evolution|September 26, 2018
Divergence and plasticity shape adaptive potential of the Pacific oysterLi Li, Ao Li, Kai Song, et al.
Emerging Microbes & Infections|November 18, 2022
Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, ChinaHongqin Xu, Hongyan Li, Hailong You, et al.
Aging and Disease|April 8, 2020
Transplantation of ACE2<sup>-</sup> Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 PneumoniaZikuan Leng, Rongjia Zhu, Wei Hou, et al.
Cancer Cell|February 25, 2024
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancerXinyuan Tong, Ayushi S Patel, Eejung Kim, et al.
Pageof 63